These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 23983192)

  • 1. Evidence for increasing usage of low-grade squamous intraepithelial lesion, cannot exclude high-grade squamous intraepithelial lesion (LSIL-H) Pap test interpretations.
    Walavalkar V; Tommet D; Fischer AH; Liu Y; Papa DM; Owens CL
    Cancer Cytopathol; 2014 Feb; 122(2):123-7. PubMed ID: 23983192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is the low-grade squamous intraepithelial lesion/atypical squamous cells cannot exclude high-grade squamous intraepithelial lesion category associated with cervical intraepithelial neoplasia 2?
    Cetiner H; Kır G; Kaygusuz E; Sağlıcan Y; Kabaca C
    Acta Cytol; 2013; 57(6):581-4. PubMed ID: 24107612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical importance of "low-grade squamous intraepithelial lesion, cannot exclude high-grade squamous intraepithelial lesion (LSIL-H)" terminology for cervical smears 5-year analysis of the positive predictive value of LSIL-H compared with ASC-H, LSIL, and HSIL in the detection of high-grade cervical lesions with a review of the literature.
    Ince U; Aydin O; Peker O
    Gynecol Oncol; 2011 Apr; 121(1):152-6. PubMed ID: 21211831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The significance of the Papanicolaou smear diagnosis of low-grade squamous intraepithelial lesion cannot exclude high-grade squamous intraepithelial lesion.
    Nasser SM; Cibas ES; Crum CP; Faquin WC
    Cancer; 2003 Oct; 99(5):272-6. PubMed ID: 14579293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The significance of "low-grade squamous intraepithelial lesion, cannot exclude high-grade squamous intraepithelial lesion" as a distinct squamous abnormality category in Papanicolaou tests.
    Elsheikh TM; Kirkpatrick JL; Wu HH
    Cancer; 2006 Oct; 108(5):277-81. PubMed ID: 16937376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of the diagnosis of low-grade squamous intraepithelial lesion, cannot exclude high-grade squamous intraepithelial lesion.
    Alsharif M; Kjeldahl K; Curran C; Miller S; Gulbahce HE; Pambuccian SE
    Cancer; 2009 Apr; 117(2):92-100. PubMed ID: 19365830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-grade squamous intraepithelial lesion, cannot rule out high-grade lesion: Diagnosis, histological outcomes and human papillomavirus results.
    Segura SE; Ramos-Rivera G; Hakima L; Suhrland M; Khader S
    Cytopathology; 2019 Jan; 30(1):99-104. PubMed ID: 30187975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of p16(INK4a) cytology testing as an adjunct to enhance the diagnostic specificity and accuracy in human papillomavirus-positive women within an organized cervical cancer screening program.
    Gustinucci D; Passamonti B; Cesarini E; Butera D; Palmieri EA; Bulletti S; Carlani A; Staiano M; D'Amico MR; D'Angelo V; Di Dato E; Martinelli N; Malaspina M; Spita N; Tintori B; Fulciniti F
    Acta Cytol; 2012; 56(5):506-14. PubMed ID: 23075891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-grade squamous intraepithelial lesion/cannot exclude high-grade squamous intraepithelial lesion (LSIL-H) is a unique category of cytologic abnormality associated with distinctive HPV and histopathologic CIN 2+ detection rates.
    Barron S; Li Z; Austin RM; Zhao C
    Am J Clin Pathol; 2014 Feb; 141(2):239-46. PubMed ID: 24436272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distribution of human papillomavirus types in ThinPrep Papanicolaou tests classified according to the Bethesda 2001 terminology and correlations with patient age and biopsy outcomes.
    Evans MF; Adamson CS; Papillo JL; St John TL; Leiman G; Cooper K
    Cancer; 2006 Mar; 106(5):1054-64. PubMed ID: 16421920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significance of high-risk human papillomavirus DNA detection in women 50 years and older with squamous cell papanicolaou test abnormalities.
    Zhao C; Zhao S; Heider A; Austin RM
    Arch Pathol Lab Med; 2010 Aug; 134(8):1130-5. PubMed ID: 20670132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "Low-grade squamous intraepithelial lesion, cannot exclude high-grade squamous intraepithelial lesion" is a distinct cytologic category: histologic outcomes and HPV prevalence.
    Owens CL; Moats DR; Burroughs FH; Gustafson KS
    Am J Clin Pathol; 2007 Sep; 128(3):398-403. PubMed ID: 17709313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The significance of ASC-H and LSIL dual interpretation with risk stratification: one institution experience.
    Gonzalez AA; Ametorgoh A; Hamele-Bena D; Everest S; Virk R; Cimic A; Tiscornia-Wasserman P
    J Am Soc Cytopathol; 2021; 10(6):565-570. PubMed ID: 34246617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LSIL/ASC-H (LSIL-H) in cervicovaginal smear: histopathological outcomes and clinical significance.
    Kaygusuz EI; Cetiner H; Sahin D
    Turk Patoloji Derg; 2011 Jan; 27(1):46-50. PubMed ID: 21469426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of high grade squamous intraepithelial lesion (HSIL) and invasive cervical cancer in patients with low grade squamous intraepithelial lesion (LSIL) at cervical pap smear.
    Khuakoonratt N; Tangjitgamol S; Manusirivithaya S; Khunnarong J; Pataradule K; Thavaramara T; Suekwattana P
    Asian Pac J Cancer Prev; 2008; 9(2):253-7. PubMed ID: 18712968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Should LSIL-H be a distinct cytology category?: A study on the frequency and distribution of 40 human papillomavirus genotypes in 808 women.
    Zhou H; Schwartz MR; Coffey D; Smith D; Mody DR; Ge Y
    Cancer Cytopathol; 2012 Dec; 120(6):373-9. PubMed ID: 22648956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Application of high-risk human papillomavirus testing in women with abnormal cytology].
    Ou H; Bian ML; Zhang XY; Chen QY; Li M; Chen Y; Liu J
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2007 Oct; 29(5):608-11. PubMed ID: 18051714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance of specific morphologic features in distinguishing low-grade squamous intraepithelial lesions from high-grade squamous intraepithelial lesions in borderline cases: a College of American Pathologists Cytopathology Committee multiobserver study.
    Staats PN; Davey DD; Witt BL; Ghofrani M; Zhao C; Dodd LG; Goodrich K; Husain M; Kurtycz DFI; Russell DK; Shen RZ; Souers RJ; Tabatabai ZL; Crothers BA
    J Am Soc Cytopathol; 2022; 11(2):102-113. PubMed ID: 34903496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defining the Longitudinal Risk of CIN 3+ for Piedimonte S; Tsang K; Jembere N; Murphy J; Karapetian T; Gao J; McCurdy B; Sacco J; Kupets R
    J Low Genit Tract Dis; 2024 Jan; 28(1):7-11. PubMed ID: 37906611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of CIN2+ /CIN3+ risk of different HPV subtypes infection combined with abnormal cytology status].
    Luo HX; Du H; Liu ZH; Zhang LJ; Wang C; Wu RF
    Zhonghua Zhong Liu Za Zhi; 2018 Mar; 40(3):232-238. PubMed ID: 29575846
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.